Fatemeh Sanie-Jahromi
Overview
Explore the profile of Fatemeh Sanie-Jahromi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanie-Jahromi F, Arman A, Attar A, Nowroozzadeh M
Cont Lens Anterior Eye
. 2024 Dec;
:102343.
PMID: 39632210
Purpose: This systematic review, evaluated the role of epidermal growth factor (EGF) in corneal wound healing and the pathogenesis of ocular surface disorders (OSDs). Methods: The clinical and experimental application...
2.
Johari M, Moallem M, Amini A, Sanie-Jahromi F
J Ophthalmol
. 2024 Nov;
2024:6662736.
PMID: 39502493
Purpose: This systematic review aims to consolidate key findings regarding the efficacy of pain relief medications administered prior to pan-retinal photocoagulation (PRP) for diabetic retinopathy (DR). Methods: A comprehensive search...
3.
Gharegezloo Z, Rezvani Z, Sanie-Jahromi F, Namjoyan F
Biomed Pharmacother
. 2024 Nov;
181:117646.
PMID: 39486365
Proliferative vitreoretinopathy (PVR) is a vision-threatening condition associated with retinal-detachment (RD), primarily caused by fibrocellular scar membrane formation. This study investigates the therapeutic potential of adlay seed extract fractions in...
4.
Sanie-Jahromi F, Hoseini S, Nowroozzadeh M
Heliyon
. 2024 Aug;
10(14):e33916.
PMID: 39092242
Purpose: Endophthalmitis is a severe infection accompanied by inflammation that affects the anterior and posterior parts of the eye. It is typically treated with a combination of antibiotics that cover...
5.
Khalili M, Shadmani A, Sanie-Jahromi F
Dev Neurobiol
. 2024 Jun;
84(3):236-248.
PMID: 38844425
Visual impairment caused by optic neuropathies is irreversible because retinal ganglion cells (RGCs), the specialized neurons of the retina, do not have the capacity for self-renewal and self-repair. Blindness caused...
6.
Sanie-Jahromi F, Khaki M, Heydari M, Nowroozzadeh M, Akbarizadeh A, Daneshamouz S, et al.
Front Med (Lausanne)
. 2024 Jun;
11:1359463.
PMID: 38831993
Background: The use of honey as an eye treatment encounters challenges due to its high osmolarity, low pH, and difficulties in sterilization. This study addresses these issues by employing a...
7.
Afarid M, Azimi A, Meshksar A, Sanie-Jahromi F
Int Ophthalmol
. 2024 May;
44(1):223.
PMID: 38727788
Purpose: This review investigates the therapeutic benefits of interferons (IFNs) in vitreoretinal diseases, focusing on their regulatory roles in innate immunological reactions and angiogenesis. The study aims to categorize the...
8.
Nowroozzadeh M, Yousefi M, Abuali M, Sanie-Jahromi F
Biomed Pharmacother
. 2024 Apr;
174:116568.
PMID: 38599062
Adalimumab (ADA) is an anti-inflammatory antibody that has FDA approval as a systemic medication for treating noninfectious uveitis. It is also provisionally being investigated as an intravitreal injection for various...
9.
Sanie-Jahromi F, Sanie Jahromi M
Cornea
. 2023 Sep;
43(1):105-110.
PMID: 37702602
Purpose: We investigated the effect of propofol (0.5, 5, and 50 μM) on the gene expression of inflammatory cytokines [ IL-1β , IL-6 , transforming growth factor β ( TGF-β...
10.
Sanie-Jahromi F, Mohsenzadeh A, Namjoyan F, Gharegezloo Z, Nejabat M
Exp Eye Res
. 2023 Sep;
235:109641.
PMID: 37696465
Corneal activated keratocytes (CAKs) -representing the injured phenotype of corneal stromal cells- are associated with several corneal diseases. Inflammatory cytokines are the key drivers of CAK formation subsequently leading to...